Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-04-29 00:00:00 ET · period of report 2022-04-27 · accession 0000899243-22-016006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-29 | 2022-04-27+ | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $2.60 | +405.7K | 4.44M | +10% | +$1.06M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-28 | P | A | 255,711 | $2.57 | 4,694,113 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-27 | P | A | 150,000 | $2.66 | 4,438,402 | D | — | — |